What is the risk for never-smokers to develop lung cancer? How does it compare in terms of risk and prevention in relation to more common cancer diagnoses?

Medical Mythbusting Commentary for March 11, 2026

Comprehensive Summary: Lung Cancer in Never-Smokers vs. Major Cancers in Canada (2025 projections)

Lung cancer causes 22% of cancer deaths in Canada; deadliest cancer.
Never-smokers: 20–30% of lung cancer cases; often diagnosed late (stage 4) due to stigma and no screening.
Main causes in never-smokers: radon (leading, ~3,200 deaths/year), secondhand smoke, air pollution (wildfires), occupational exposures (asbestos, diesel), genetics.
Age-standardized incidence rates per 100,000:
- Never-smoker lung cancer: ~10–20
- Overall lung & bronchus: ~77
- Prostate (males): ~152
- Breast (females): ~147
- Colorectal: ~50–60
Never-smoker lung cancer rate is 2–15 times lower than top cancers.
Mass screening of never-smokers: not recommended; low incidence → CT radiation risks outweigh benefits; current programs target only high-risk smokers/former smokers (20% mortality reduction).
Prevention priorities: home radon testing, improved air quality.

Lifetime cancer risk from yearly LDCT lung cancer screening in never-smokers: primarily radiation-induced risk.

Annual LDCT dose: ~1–2 mSv (effective).
Cumulative over 20–30 years (e.g., ages 50–80): ~20–60 mSv.
Estimated lifetime attributable risk of radiation-induced cancer: ~0.05–0.25% (0.5–2.5 per 1,000 screened), higher in women (~2–3× men) and if starting younger.
Radiation-induced lung cancer mortality risk: ~1–3 per 10,000 (0.01–0.03%) for limited rounds; scales up with more annual scans.
Overall induced fatal cancers: low (e.g., 0.1–0.24 per 1,000 in some models for fewer rounds), but non-negligible for never-smokers due to low baseline lung cancer risk.
No net benefit in never-smokers; harms (radiation risk, false positives, overdiagnosis) outweigh potential gains; screening not recommended.

Standardized annual incidence per 100,000 (apples-to-apples comparator):